TVB-3567 — Clinical data readout
2026
Phase 1 clinical trial results anticipated in 2026, Phase 2 proof of concept clinical trial anticipated to begin before the end of 2026, subject to regulatory feedbackSource filing
SGMT biotech catalysts & pipeline
SAGIMET BIOSCIENCES INC · Data as of 2026-10-25
Upcoming catalysts
denifanstat — Clinical data readout
1H2027
Phase 1 results expected 1H2027Source filing
denifanstat — Topline data
H2 2027
"Our focus is on advancing this registrational trial, with topline results expected in the second half of 2027.Source filing